Current Status of Immunotherapy for Localized and Locally Advanced Renal Cell Carcinoma
Ghali F, Patel S, Derweesh I. Current Status of Immunotherapy for Localized and Locally Advanced Renal Cell Carcinoma. Journal Of Oncology 2019, 2019: 7309205. PMID: 31057615, PMCID: PMC6463563, DOI: 10.1155/2019/7309205.Peer-Reviewed Original ResearchAdvanced renal cell carcinomaRenal cell carcinomaAdjuvant therapyNeoadjuvant therapyCell carcinomaMetastatic renal cell carcinomaTyrosine kinase inhibitor sunitinibPresurgical tumor reductionSystemic therapy strategiesFirst-line therapyPhase II studyNephron-sparing surgeryPrimary renal tumorsKinase inhibitor sunitinibNeoadjuvant immunotherapyNeoadjuvant strategiesII studyLine therapySurgical resectionRadical resectionCheckpoint inhibitionAdjuvant agentTumor reductionRenal tumorsClinical trials